Lunai Bioworks LNAI
NASDAQ LNAI
$1.30 -0.08 (-5.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Return on Capital Employed [ROCE] (2013 - 2025)

Updated

Lunai Bioworks' Return on Capital Employed [ROCE] came in at -558.70% for fiscal Q4 2025 (quarter ended Jun 30, 2025), down 500.51 percentage points from -58.19% a year earlier and down 466.33 percentage points from the prior quarter.

Analysis

Lunai Bioworks (LNAI) Return on Capital Employed [ROCE] (2013 - 2025) Analysis & Trends

For FY2025 (ended Jun 30, 2025), Lunai Bioworks' Return on Capital Employed [ROCE] was -334.31%, down 232.78 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -327.60 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, Return on Capital Employed [ROCE] was -101.53% in FY2024 (-37.75 pp), -63.79% in FY2023 (+25.05 pp), -88.84% in FY2022 (-75.97 pp) and -12.86% in FY2021 (-6.15 pp).
  • The fiscal Q4 2025 figure represents the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q3 2016.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for four consecutive quarters, with an average year-over-year change of -44.06 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in fiscal Q3 2024 (a gain of 78.06 percentage points), and the weakest in fiscal Q4 2025 (a drop of 500.51 percentage points).
  • Business Quant data shows LNAI's Return on Capital Employed [ROCE] at -92.37% (Q3 2025), -143.64% (Q2 2025) and -105.57% (Q1 2025) in the three fiscal quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Lunai Bioworks 4.06 Mn -690,718.65 20,942.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -558.70%
Mar 31, 2025 -92.37%
Dec 31, 2024 -143.64%
Sep 30, 2024 -105.57%
Jun 30, 2024 -58.19%
Mar 31, 2024 -90.01%
Dec 31, 2023 -91.19%
Sep 30, 2023 -84.14%
Jun 30, 2023 -67.06%
Mar 31, 2023 -168.07%
Dec 31, 2022 -161.70%
Sep 30, 2022 -150.95%
Jun 30, 2022 -92.19%
Mar 31, 2022 -18.41%
Dec 31, 2021 -17.52%
Sep 30, 2021 -15.11%
Jun 30, 2021 -13.02%
Mar 31, 2021 -7.01%
Dec 31, 2020 -7.44%
Sep 30, 2020 -7.02%
API Access

Lunai Bioworks Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LNAI&period=max&api_key=YOUR_API_KEY